Cargando…
Hepatotoxic Evaluation of N-(2-Hydroxyphenyl)-2-Propylpentanamide: A Novel Derivative of Valproic Acid for the Treatment of Cancer
Valproic acid (VPA) is a drug that has various therapeutic applications; however, it has been associated with liver damage. Furthermore, it is interesting to propose new compounds derived from VPA as N-(2-hydroxyphenyl)-2-propylpentanamide (HO-AAVPA). The HO-AAVPA has better antiproliferative activi...
Autores principales: | Correa Basurto, Ana María, Tamay Cach, Feliciano, Jarillo Luna, Rosa Adriana, Cabrera Pérez, Laura Cristina, Correa Basurto, José, García Dolores, Fernando, Mendieta Wejebe, Jessica Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488843/ https://www.ncbi.nlm.nih.gov/pubmed/37687111 http://dx.doi.org/10.3390/molecules28176282 |
Ejemplares similares
-
N-(2′-Hydroxyphenyl)-2-Propylpentanamide (HO-AAVPA) Inhibits HDAC1 and Increases the Translocation of HMGB1 Levels in Human Cervical Cancer Cells
por: Sixto-López, Yudibeth, et al.
Publicado: (2020) -
N-(2′-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells
por: Contis-Montes de Oca, Arturo, et al.
Publicado: (2018) -
Correction: N-(2´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells
por: Contis-Montes de Oca, Arturo, et al.
Publicado: (2019) -
PAMAM-G4 protect the N-(2-hydroxyphenyl)-2-propylpentanamide (HO-AAVPA) and maintain its antiproliferative effects on MCF-7
por: Ortiz-Morales, Alma Alicia, et al.
Publicado: (2023) -
In Vivo and Ex Vivo Evaluation of 1,3-Thiazolidine-2,4-Dione Derivatives as Euglycemic Agents
por: Alemán-González-Duhart, Diana, et al.
Publicado: (2021)